DEBRICHEM® supplement published in the Journal of Wound Care

Our novel debriding agent, DEBRICHEM®, has recently been featured in a 3 article supplement in the Journal of Wound Care. The articles provide an introduction to debridement with an overview of current debridement techniques and introduce DEBRICHEM® as a new option for chemical debridement, followed by a seven-patient case series from the United Kingdom.

DEBRICHEM® represents a significant advancement in the field of debridement, offering a unique solution to overcome limitations associated with conventional approaches.

The compelling case series encompassed seven patients with recalcitrant wounds that exhibited a lack of improvement despite receiving standard care for prolonged periods, ranging from 12 months to an astonishing 17 years.

Following treatment with DEBRICHEM®, all cases displayed remarkable healing progress, characterized by a decrease in wound size, substantial resolution of slough, decrease in exudate level and robust production of granulation tissue.

See the images below for a summary per case.

DEBRICHEM®’s proprietary formulation is meticulously engineered to remove biofilm and infection from a wound, triggering the onset of the natural healing process in a single 60-second application. With its ease of use and exceptional efficacy, DEBRICHEM® represents a promising alternative to conventional debridement techniques.

We invite the scientific community to delve into these articles, embracing our shared vision to transform wound care practices and advance patient well-being. The supplement is free to read and download via the Journal of Woundcare educational resources on MagOnline.

CLICK HERE to access the full article

More Posts


Today marks the 2nd annual International Stop Wound Infection Day. This day is about raising awareness of effective identification, prevention and management strategies for wound

Get in touch


Login to get access to our case reports.


Login to your account